Key2compliance expanderar till Danmark

För första gången etablerar sig medicinteknik- och läkemedelskonsulterna Key2compliance utanför Sveriges gränser.

Carl Borrebaeck – professor and serial entrepreneur with a taste for speed

Award-winning cancer researcher, the founder of many listed companies, and constantly in the academic and commercial spotlight for decades. However, Carl Borreb...

Amorphous materials take centre stage when Orexo develops new formulations

Swift resolution but with maintained stability. Orexo’s new drug delivery platform tackles the problem of amorphous materials. “Our technology has the positive ...

Han är ny vd på Brighter

Healthtechbolaget Brighter har utsett Erik Lissner till tillförordnad vd och hoppas att turbulensen kring ledarskapet är över.

“An entire industry is about to be wiped out”

According to Jennie Ekbeck, CEO of Umeå Biotech Incubators, Sweden risks not having any small diagnostic companies left in five years.

Losec tar plats i matbutikerna

Läkemedelsverket ökar tillgängligheten till Astrazenecas storsäljare, och bolaget får svar från FDA.

Björn Ursing: Physicians new role in AI driven healthcare

”AI could be the key we need for tomorrow’s healthcare, but it is not a stand-alone tool”, writes Björn Ursing in a column about how the role for physicians cha...

Stockholm aims at becoming one of the world’s top life science regions

Regional Chair for Finance, Irene Svenonius (M), believes that Stockholm can realise the goal of becoming one of the world’s top 5 regions in life science by 20...

Calliditas beviljas prioriterad granskning

Calliditas läkemedel Nefecon mot Bergers sjukdom kan bli godkänt av FDA i september.

IVI’s Director General on establishing in Sweden: Will need up to 40 employees

The International Vaccine Institute, IVI, hopes to have its first staff on-site in Stockholm within a couple of months, says the institute’s Director General Je...

Founder of Bioarctic, Lars Lannfelt, is honoured: “I want to create something for the future”

It´s like a scientist’s dream: to be the world’s first with a drug that genuinely affects one of our major diseases. Lars Lannfelt and his company Bioarctic hav...

Saving lives worldwide with low-cost molecular diagnostics

High throughput testing for many upper respiratory tract pathogens thanks to automation technology

IRW Consulting is seeking Clinical Research Associates (CRAs) on positions located in Stockholm

Oncopeptides har ansökt om tillstånd för kliniska studier i USA

Oncopeptides planerar att påbörja kliniska studier i USA med deras andra läkemedelskandidat för patienter med multipelt myelom.

IRW Consulting is seeking Clinical Research Managers

Anställer affärsutvecklare

Bioteknikbolaget Acousort har anställt Kristian Enqvist som affärsutvecklingschef på konsultbasis.

Anställer affärsutvecklare

Bioteknikbolaget Acousort har anställt Kristian Enqvist som affärsutvecklingschef på konsultbasis.

Delivering drugs with small devices

There are many challenges to overcome when delivering a drug orally. Getting the drug to survive the low pH of the ventricle and being released at the correct s...

Marie Gårdmark: Big data evidence generation drives change in the EU regulatory system

Rapid developments in technology have led to the possibility for the generation and analysis of vast volumes of data. Will the availability of big data lead to ...

When carelessness, forgetfulness and coincidence become the researcher’s best friend

Forgetfulness, coincidence and a stroke of luck hardly make up a fruitful method of serious research. Or do they? Actually, a number of important medical advanc...

Studieklart för Hansa

Hansa biopharma har fått godkänt att starta fas 2-studie med imlifidase i akut AMR i samband med njurtransplantation.

Nässpray mot depression nära

Har en helt ny verkningsmekanism än de nuvarande tillgängliga behandlingsalternativen mot depression.

Swedenbio Summit 2017

Mötet öppnades med en intervju, där nya vice vd:n och policychefen Helena Strigård, intervjuade kansliet. Vad får våra medlemmar för avgiften, frågade hon.

Microwave reactor for use in various synthesis applications

The Monowave 300 microwave reactor offers 850 watts of power for a variety of synthesis applications.